Dr. Chandler Park discusses the importance of genetic testing and personalized care in patients with genitourinary cancers.

In this study, non-directiveness applies to the approach of the counselling team towards family members besides the proband. When a BRCA1/2 gene mutation is found in a family, the possibility of ...

During the Feb. 11 event, Chris Evert and Martina Navratilova discussed memorable tournaments, double dates and their ...

Background PARP inhibitors (PARPi) have been licensed for the maintenance therapy of patients with metastatic pancreatic cancer carrying pathogenic germline BRCA1/2 mutations. However, mutations in ...

Most studies assessing BPO are retrospective studies and nonrandomized ( Table 1) and have been evaluated in women at risk for carrying BRCA1/2 mutations. A study by Lu et al [42] reviewed the ...

AI chipmaker Nvidia and research partners have created what they call the largest artificial intelligence system yet for ...

This material on this page is ©2025 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please ...

NVIDIA (NASDAQ: NVDA) has introduced Evo 2, an advanced artificial intelligence (AI) system aimed at transforming the field ...

cmft.nhs.uk Background While the requirement for thresholds for testing for mutations in BRCA1/2 is being questioned, they are likely to remain for individuals unaffected by a relevant cancer. It is ...

A bill that would require private Idaho health insurers to cover supplemental breast cancer screenings for high-risk patients ...

The researchers found that having ever used oral contraception reduced odds of ovarian cancer by 26% (odds ratio [OR], 0.74; 95% CI, 0.66-0.84). Further, those who stopped using oral contraception at ...